MUC16 and neoplasm: Several aspects need to be discussed as potential cofactors for the negative impact of MUC16 (+) on survival, i.e., MUC16 (+) patients had higher Pn status, more frequently positive serum levels of tumor marker CA-19/9, and increased Ki-67 proliferative index.